Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions

Imagem de Miniatura
Arquivos
art_HAAS_Banff_2013_Meeting_Report_Inclusion_of_C4d_Negative_2014.PDF (533.52 KB)
Citações na Scopus
1153
Tipo de produção
article
Data de publicação
2014
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY-BLACKWELL
Autores
HAAS, M.
SIS, B.
RACUSEN, L. C.
SOLEZ, K.
GLOTZ, D.
COLVIN, R. B.
BAGNASCO, S. M.
Citação
AMERICAN JOURNAL OF TRANSPLANTATION, v.14, n.2, p.272-283, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The 12th Banff Conference on Allograft Pathology was held in Comandatuba, Brazil, from August 19-23, 2013, and was preceded by a 2-day Latin American Symposium on Transplant Immunobiology and Immunopathology. The meeting was highlighted by the presentation of the findings of several working groups formed at the 2009 and 2011 Banff meetings to: (1) establish consensus criteria for diagnosing antibody-mediated rejection (ABMR) in the presence and absence of detectable C4d deposition; (2) develop consensus definitions and thresholds for glomerulitis (g score) and chronic glomerulopathy (cg score), associated with improved inter-observer agreement and correlation with clinical, molecular and serological data; (3) determine whether isolated lesions of intimal arteritis (isolated v) represent acute rejection similar to intimal arteritis in the presence of tubulointerstitial inflammation; (4) compare different methodologies for evaluating interstitial fibrosis and for performing/evaluating implantation biopsies of renal allografts with regard to reproducibility and prediction of subsequent graft function; and (5) define clinically and prognostically significant morphologic criteria for subclassifying polyoma virus nephropathy. The key outcome of the 2013 conference is defining criteria for diagnosis of C4d-negative ABMR and respective modification of the Banff classification. In addition, three new Banff Working Groups were initiated.
Palavras-chave
Acute allograft rejection, antibody-mediated rejection, Banff schema, cardiac allograft, chronic allograft rejection, complement C4d, composite tissue allograft, donor-specific antibodies, liver allograft, lung transplantation, pancreas allograft, renal transplantation, transplant biopsy, transplant glomerulopathy, transplant pathology
URI
https://observatorio.fm.usp.br/handle/OPI/7791
Referências
  1. Batal I, 2010, AM J TRANSPLANT, V10, P2442, DOI 10.1111/j.1600-6143.2010.03261.x
  2. Berry G, 2013, J HEART LUNG TRANSPL, V32, P14, DOI 10.1016/j.healun.2012.11.005
  3. Berry GJ, 2013, J HEART LUNG TRANSPL, V32, P1147, DOI 10.1016/j.healun.2013.08.011
  4. Bravou V, 2013, CLIN NEPHROL, V80, P306, DOI 10.5414/CN107462
  5. Drachenberg CB, 2011, AM J TRANSPLANT, V11, P1792, DOI 10.1111/j.1600-6143.2011.03670.x
  6. Einecke G, 2009, AM J TRANSPLANT, V9, P2520, DOI 10.1111/j.1600-6143.2009.02799.x
  7. Haas M, 2006, AM J TRANSPLANT, V6, P1829, DOI 10.1111/j.1600-6143.2006.01356.x
  8. Haas M, 2013, CURR OPIN ORGAN TRAN, V18, P319, DOI 10.1097/MOT.0b013e32835d4daf
  9. Haas M, 2011, AM J TRANSPLANT, V11, P2123, DOI 10.1111/j.1600-6143.2011.03647.x
  10. Hayde N, 2013, TRANSPLANTATION, V95, P580, DOI 10.1097/TP.0b013e318277b2e2
  11. Hidalgo LG, 2010, AM J TRANSPLANT, V10, P1812, DOI 10.1111/j.1600-6143.2010.03201.x
  12. Kaufman CL, 2012, AM J TRANSPLANT, V12, P1004, DOI 10.1111/j.1600-6143.2011.03915.x
  13. Lefaucheur C, 2013, LANCET, V381, P313, DOI 10.1016/S0140-6736(12)61265-3
  14. Liapis G, 2012, TRANSPLANTATION, V94, P620, DOI 10.1097/TP.0b013e31825f4df4
  15. Loupy A, 2009, AM J TRANSPLANT, V9, P2561, DOI 10.1111/j.1600-6143.2009.02813.x
  16. Loupy A, 2011, AM J TRANSPLANT, V11, P56, DOI 10.1111/j.1600-6143.2010.03364.x
  17. Mannon RB, 2010, AM J TRANSPLANT, V10, P2066, DOI 10.1111/j.1600-6143.2010.03240.x
  18. Margreiter C, 2012, TRANSPLANTATION, V93, P207, DOI 10.1097/TP.0b013e31823cf953
  19. Mengel M, 2009, AM J TRANSPLANT, V9, P1859, DOI 10.1111/j.1600-6143.2009.02727.x
  20. Mengel M, 2013, AM J TRANSPLANT, V13, P1235, DOI 10.1111/ajt.12193
  21. Mengel M, 2012, AM J TRANSPLANT, V12, P563, DOI 10.1111/j.1600-6143.2011.03926.x
  22. Meuli-Simmen C, 1996, MICROSURG, V17, P551, DOI 10.1002/(SICI)1098-2752(1996)17:10<551::AID-MICR4>3.0.CO;2-T
  23. Miller DV, 2013, J HEART LUNG TRANSPL, V32, pS20
  24. Mundinger GS, 2013, TRANSPLANTATION, V95, P1204, DOI 10.1097/TP.0b013e31828d1528
  25. Niederhaus SV, 2013, AM J TRANSPLANT, V13, P2945, DOI 10.1111/ajt.12443
  26. Papadimitriou JC, 2013, TRANSPLANTATION, V95, P128, DOI 10.1097/TP.0b013e3182777f28
  27. Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x
  28. Racusen LC, 2003, AM J TRANSPLANT, V3, P708, DOI 10.1034/j.1600-6143.2003.00072.x
  29. Seemayer CA, 2007, NEPHROL DIAL TRANSPL, V22, P568, DOI 10.1093/ndt/gfl594
  30. Setoguchi K, 2008, AM J TRANSPLANT, V8, P86, DOI 10.1111/j.1600-6143.2007.02036.x
  31. Sis B, 2009, AM J TRANSPLANT, V9, P2312, DOI 10.1111/j.1600-6143.2009.02761.x
  32. Sis B, 2012, AM J TRANSPLANT, V12, P1168, DOI 10.1111/j.1600-6143.2011.03931.x
  33. Snyder LD, 2013, CHEST, V144, P226, DOI 10.1378/chest.12-0587
  34. Stegall MD, 2011, AM J TRANSPLANT, V11, P2405, DOI 10.1111/j.1600-6143.2011.03757.x
  35. Tan CD, 2009, AM J TRANSPLANT, V9, P2075, DOI 10.1111/j.1600-6143.2009.02748.x
  36. Unadkat JV, 2010, AM J TRANSPLANT, V10, P251, DOI 10.1111/j.1600-6143.2009.02941.x
  37. Wavamunno MD, 2007, AM J TRANSPLANT, V7, P2757, DOI 10.1111/j.1600-6143.2007.01995.x
  38. Witt CA, 2013, J HEART LUNG TRANSPL, V32, P1034, DOI 10.1016/j.healun.2013.07.004

Coleções
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/16